首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   736篇
  免费   4篇
  国内免费   1篇
化学工业   13篇
金属工艺   1篇
机械仪表   2篇
建筑科学   1篇
能源动力   3篇
轻工业   5篇
无线电   6篇
一般工业技术   17篇
冶金工业   675篇
自动化技术   18篇
  2021年   1篇
  2019年   1篇
  2018年   1篇
  2017年   2篇
  2016年   2篇
  2014年   3篇
  2013年   5篇
  2012年   4篇
  2011年   6篇
  2010年   4篇
  2009年   2篇
  2008年   1篇
  2007年   4篇
  2005年   7篇
  2004年   3篇
  2003年   4篇
  2002年   1篇
  2000年   1篇
  1999年   14篇
  1998年   193篇
  1997年   112篇
  1996年   83篇
  1995年   43篇
  1994年   46篇
  1993年   42篇
  1992年   7篇
  1991年   9篇
  1990年   7篇
  1989年   5篇
  1988年   7篇
  1987年   12篇
  1986年   6篇
  1985年   3篇
  1984年   1篇
  1983年   2篇
  1982年   4篇
  1981年   3篇
  1980年   3篇
  1978年   2篇
  1977年   24篇
  1976年   55篇
  1975年   1篇
  1955年   2篇
  1954年   1篇
  1908年   2篇
排序方式: 共有741条查询结果,搜索用时 0 毫秒
121.
A new diagnostic procedure was developed to detect the flagellar antigen of Campylobacter jejuni and Campylobacter coli in canine faecal specimens and was tested on faecal samples from random-source dogs obtained from the local dog pound. Extraction of acid-soluble proteins was performed on faecal specimens and the extracted material was evaluated using species-specific monoclonal antibodies in an enzyme-linked immunosorbent assay. The assay detected all C. jejuni or C. coli infected specimens compared with direct selective faecal culture. One of 18 faecal specimens culture-negative for C. jejuni was identified as positive by the assay, i.e. a false positive rate of 1 of 18 (5.6%) and a corresponding specificity of 94.4%. These results suggest that the screening procedure developed to detect flagellar antigens of C. jejuni and C. coli in canine faecal samples should be further investigated as a diagnostic alternative to culture.  相似文献   
122.
In 17 previously reported cases of cladosporiosis, no reliable therapy was described, and death occurred usually within one year of diagnosis. Pretreatment isolates from our two patients were inhibited by 6.2 mug/ml and 3.1mug/ml of flucytosine, respectively. Although both patients died, postmortem examination results showed that in one patient, the fungus had been eradicated. In the other patient, C trichoides that was isolated at postmortem examination was resistant to flucytosine treatment.  相似文献   
123.
Pehnotypings of serum proteins and erythrocyte enzyme polymorphisms were used in addition to classic erythrocyte antigens in a study of 281 paternity cases. This group was compared with 877 cases in which only the erythrocyte antigens were tested. In the study group 80 exclusions were found for 52 alleged fathers. The expanded test battery increased the exclusion rate by 62%. In addition to 30 direct exclusions, serum proteins and erythrocyte enzymes corroborated indirect exclusions obtained with erythrocyte antigen tests in eight instances.  相似文献   
124.
The results from short-term tests for genetic and related effects, abstracted from the open literature for 36 anticancer drugs, are examined in this review. Data for 27 of these agents are available in the EPA/IARC Genetic Activity Profile (GAP) database. Data summaries, including data listings and activity profiles, are presented for nine anticancer drugs added to the GAP database for this analysis. Genetic toxicity data from the recent literature are included for the additional agents to provide a broader representation of the categories of drugs being evaluated. These categories, based on the chemical mode of action, are covalent and noncovalent DNA-binding drugs, topoisomerase II inhibitors, antimetabolites, mitotic spindle inhibitors, and drugs which affect endocrine function. The qualitative data for all 36 drugs are summarized in this report and findings are presented from pair-wise matching of genetic activity profiles, based on test results in common, for some chemical analogs. The significance of germ cell test results for some of these drugs and their implication in assessing risk of heritable genetic disease are discussed.  相似文献   
125.
126.
127.
The present investigation was designed to determine the effect of propranolol on regional myocardial blood flow and oxygen consumption (MVO2) in the isolated supported dog heart preparation perfused at a constant coronary blood flow. The transmural distribution of blood flow, determined by the radioactive microsphere technique, was expressed as the epicardial/endocardial blood flow ratio (epi/endo). Propranolol (0.5 mg/kg i.v.) produced a significant decrease in heart rate and myocardial contractile force and an increase in coronary artery perfusion pressure due to an increase in coronary vascular resistance. These hemodynamic changes were accompanied by significant decreases in epi/endo (increased endocardial perfusion) and MVO2. Reduction of perfusion pressure to control by a decrease in total coronary blood flow produced no further change in epi/endo or MVO2. However, increasing heart rate to control increased epi/endo to predrug levels. Contractile force and MVO2 remained reduced below control. Norepinephrine infusion (1 mug/min intracoronary) produced a significant increase in heart rate and contractile force and decrease in perfusion pressure. These changes were accompanied by an increase in epi/endo and MVO2. Propranolol (0.5 mg/kg i.v.) abolished the response to norepinephrine. Propranolol may produce beneficial effects in angina pectoris by a decrease in epi/endo (via a reduction in heart rate) and MVO2 and by beta adrenergic blockade of the deleterious effects of catecholamines.  相似文献   
128.
129.
130.
A system by which children with impaired hearing are given early audiological treatment is reported. The treatment has been carried out during short admissions to institution alternating with stays at home. Special training and instruction of the parents are important. The authors are of the opinion that this type of preschool training is suitable for regions with scattered population. Even a small institution with a limited staff can give treatment to a considerable number of children.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号